Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion type Assertion NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_head.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion description "[The subjects of this study were 45 patients with locally advanced breast cancer (LABC), who received the cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) regimen as NACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_provenance.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion evidence source_evidence_literature NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_provenance.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion SIO_000772 21431478 NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_provenance.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion wasDerivedFrom befree-20140225 NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_provenance.
- NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_assertion wasGeneratedBy ECO_0000203 NP793850.RAQrVAbWpB8v6FsxOU5ziNEfQ2ykmJVGy9cURB7UgGTqU130_provenance.